Nandrolone-pretreatment enhances cardiac β2-adrenoceptor expression and reverses heart contractile down-regulation in the post-stress period of acute-stressed rats

Journal of Steroid Biochemistry and Molecular Biology

Volumn 107, Issue 1-2, 2007, Pages 106-113

  Penna, Claudia ^a   Abbadessa, Giuliana ^a   Mancardi, Daniele ^a   Spaccamiglio, Angela ^a   Racca, Silvia ^a   Pagliaro, Pasquale ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Adrenoceptors; Contractility; Isolated heart; Nandrolone decanoate; Stress

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; ISOPRENALINE; NANDROLONE DECANOATE;

ACUTE STRESS; ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; HEART DISEASE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE DP-DT; IMMOBILIZATION STRESS; INOTROPISM; ISOLATED HEART; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RISK FACTOR; SPRAGUE DAWLEY RAT;

ACUTE DISEASE; ANABOLIC AGENTS; ANIMALS; MYOCARDIAL CONTRACTION; MYOCARDIUM; NANDROLONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-2; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL;

ANIMALIA; RATTUS;

EID: 34548412607     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.05.005     Document Type: Article

References (36)

1. Benjamin I.J., Jalil J.E., Tan L.B., Cho K., Weber K.T., and Clark W.A. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ. Res. 65 (1989) 657-670
2. Bünemann M., Lee K.B., Pals-Rylaarsdam R., Roseberry A.G., and Hosey M.M. Desensitization of G-protein-coupled receptors in the cardiovascular system. Ann. Rev. Physiol. 61 (1999) 169-192
3. Chang D.H., and Einstein R. Changes in cardiovascular responsiveness to dopexamine and beta 1- and beta2-adrenoceptor function after the chronic treatment of beta-adrenoceptor antagonists and agonists in anaesthetized dogs. J. Auton. Pharmacol. 16 (1996) 269-279
4. Mak J.C., Nishikawa M., and Barnes P.J. Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 268 (1995) L41-L46
5. Schlussman S.D., Zhou Y., Johansson P., Kiuru A., Ho A., Nyberg F., and Kreekm M.J. Effects of the androgenic anabolic steroid, nandrolone decanoate, on adrenocorticotropin hormone, corticosterone and proopiomelanocortin, corticotropin releasing factor (CRF) and CRF receptor1 mRNA levels in the hypothalamus, pituitary and amygdala of the rat. Neurosci. Lett. 284 (2000) 190-194
6. Lindblom J., Kindlundh A.M.S., Nyberg F., Bergstrom L., and Wikberg J.E.S. Anabolic androgenic steroid nandrolone decanoate reduces hypothalamic propiomelanocortin mRNA levels. Brain Res. 986 (2003) 139-147
7. Trifunovic B., Norton G.R., Duffield M.J., Avraam P., and Woodiwiss A.J. An androgenic steroid decreases left ventricular compliance in rats. Am. J. Physiol. Heart Circ. Physiol. 268 (1995) H1096-H1105
8. Norton G.R., Trifunovic B., and Woodiwiss A.J. Attenuated beta-adrenoceptor-mediated cardiac contractile responses following androgenic steroid administration to sedentary rats. Eur. J. Appl. Physiol. 81 (2000) 310-316
9. Pesola M.K. Reversibility of the haemodynamic effects of anabolic steroids in rats. Eur. J. Appl. Physiol. Occup. Physiol. 58 (1988) 125-131
10. Thorén P.N. Reflex effects of left ventricular mechanoreceptors with afferent fibers in the vagal nerves. In: Hainsworth R., Kidd C., and Linden R.J. (Eds). Cardiac Receptors (1979), Cambridge University Press, Cambridge, UK 259-277
11. Pagliaro P., Chiribiri A., Gattullo D., Penna C., Rastaldo R., and Recchia F.A. Fatty acids are important for the Frank-Starling mechanism and Gregg effect but not for catecholamine response in isolated rat hearts. Acta Physiol. Scand. 176 (2002) 167-176
12. Phillis B.D., Irvine R.J., and Kennedy J.A. Combined cardiac effects of cocaine and the anabolic steroid, nandrolone, in the rat. Eur. J. Pharmacol. 398 (2000) 263-272
13. Reyes T.M., Walker J.R., DeCino C., Hogenesch J.B., and Sawchenko P.E. Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J. Neurosci. 23 (2003) 5607-5616
14. Paolocci N., Ekelund U.E., Isoda T., Ozaki M., Vandegaer K., Georgakopoulos D., Harrison R.W., Kass D.A., and Hare J.M. cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H1928-H1982
15. Rastaldo R., Paolocci N., Chiribiri A., Penna C., Gattullo D., and Pagliaro P. Cytochrome P-450 metabolite of arachidonic acid mediates bradykinin-induced negative inotropic effect. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H2823-H2832
16. Gregg D.E. Effect of coronary perfusion pressure or coronary flow on oxygen usage of the myocardium. Circ. Res. 13 (1963) 497-500
17. Thawornkaiwong A., Preawnim S., and Wattanapermpool J. Upregulation of beta 1-adrenergic receptors in ovariectomized rat hearts. Life Sci. 72 (2003) 1813-1824
18. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Annal. Biochem. 72 (1976) 248-254
19. Ejike J.C., Arakaki L.S., Beard D.A., Ciesielski W.A., Feigl E.O., and Schenkman K.A. Myocardial oxygenation and adenosine release in isolated guinea pig hearts during changes in contractility. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H2062-H2067
20. Xiao R.P., Cheng H., Zhou Y.Y., Kuschel M., and Lakatta E.G. Recent advances in cardiac beta (2)-adrenergic signal transduction. Circ. Res. 85 (1999) 1092-1100
21. Liggett S.B., Tepe N.M., Lorenz J.N., Canning A.M., Jantz T.D., Mitarai S., Yatani A., and Dorn II G.W. Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 101 (2000) 1707-1714
22. McGraw D.W., Chai S.E., Hiller F.C., and Cornett L.E. Regulation of the beta 2-adrenergic receptor and its mRNA in the rat lung by dexamethasone. Exp. Lung Res. 21 (1995) 535-546
23. Dangel V., Giray J., Ratge D., and Wisser H. Regulation of beta-adrenoceptor density and mRNA levels in the rat heart cell-line H9c2. Biochem. J. 317 (1996) 925-931
24. Losel R.M., Falkenstein E., Feuring M., Schultz A., Tillmann H.C., Rossol-Haseroth K., and Wehling M. Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev. 83 (2003) 965-1016
25. Wehling M., and Losel R. Non-genomic steroid hormone effects: membrane or intracellular receptors?. J. Steroid Biochem. Mol. Biol. 102 (2006) 180-183
26. Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 463 (2003) 235-272
27. Irving R.J., White J., and Chan R. The influence of restraint on blood pressure in the rat. J. Pharmacol. Toxicol. Methods 38 (1997) 157-162
28. Thiblin I., and Petersson A. Pharmacoepidemiology of anabolic androgenic steroids: a review. Fundam. Clin. Pharmacol. 19 (2005) 27-44
29. Petersson A., Garle M., Granath F., and Thiblin I. Morbidity and mortality in patients testing positively for the presence of anabolic androgenic steroids in connection with receiving medical care. A controlled retrospective cohort study. Drug Alcohol Depend. 81 (2006) 215-220
30. Bhatnagar S., and Dallman M. Neuroanatomical basis for facilitation of hypothalamic-pituitary-adrenal responses to a novel stressor after chronic stress. Neuroscience 84 (1998) 1025-1039
31. Pitman D.L., Ottenweller J.E., and Natelson B.H. Plasma corticosterone levels during repeated presentation of two intensities of restraint stress: chronic stress and habituation. Physiol. Behav. 43 (1988) 47-55
32. Kvetnansky R., Pacak K., Fukuhara K., Viskupic E., Hiremagalur B., Nankova B., Goldstein D.S., Sabban E.L., and Kopin I.J. Sympathoadrenal system in stress. Interaction with the hypothalamic-pituitary-adrenocortical system. Ann. NY Acad. Sci. 771 (1995) 131-158
33. Aguilera G., and Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Reg. Pept. 96 (2000) 23-29
34. Racca S., Spaccamiglio A., Esculapio P., Abbadessa G., Cangemi L., Di Carlo F., and Portaleone P. Effects of swim stress and alpha-MSH acute pre-treatment on brain 5-HT transporter and corticosterone receptor. Pharmacol. Biochem. Behav. 81 (2005) 894-900
35. Curtis A.L., Bell N.T., and Valentino R.J. Evidence for functional release of endogenous opioids in the locus ceruleus during stress termination. J. Neurosci. 21 (2001) RC152
36. Pacak K., and Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr. Rev. 22 (2001) 502-548